NBIX- Neurocrine Biosciences, Inc.

Name: Neurocrine Biosciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Gano Kyle	140.4K	$23.32M	-
Other	Benevich Eric	52.8K	$8.76M	-
Other	Lippoldt Darin	46.8K	$7.76M	-
Other	Cooke Julie	39.6K	$6.58M	-36,937
Other	Onyia Jude	36.8K	$6.12M	-22,000

Activity

Buys and sells only

Transactions

10 filings · page 25

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Nov 12, 2020	Gorman Kevin Charles55	Chief Executive Officer	Sell	3,390	$90.78	$307,747.59	-0.8%
Nov 12, 2020	Gano Kyle54	Chief Business Development Off	Sell	2,257	$90.73	$204,770.39	-2.3%
Nov 12, 2020	Cooke Julie59	Chief Human Resources Officer	Sell	2,257	$90.73	$204,777.61	-16.3%
Nov 12, 2020	Bozigian Haig P.	Chief Development Officer	Sell	2,257	$90.74	$204,806.50	-1.5%
Nov 12, 2020	Abernethy Matt57	Chief Financial Officer	Sell	2,257	$90.74	$204,810.11	-18.4%
Nov 2, 2020	Benevich Eric62	Chief Commercial Officer	Sale+OE	20,595	$96.53	$1,987,971.51	-57.3%
Oct 2, 2020	Cooke Julie59	Chief Human Resources Officer	Sell	987	$95.26	$94,021.62	-9.4%
Aug 5, 2020	Roberts Eiry49	Chief Medical Officer	Sell	2,257	$118.84	$268,225.27	-16.5%
Aug 5, 2020	Lloyd-Smith Malcolm49	Chief Regulatory Officer	Sell	2,257	$118.86	$268,277.40	-7.7%
Aug 5, 2020	Lippoldt Darin60	Chief Legal Officer	Sell	2,257	$118.87	$268,297.26	-7.4%

← PrevPage 25Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC